Cefdinir Impurity 4 | CAS 137054-66-1 - Request Quote
Cefdinir Impurity 4
| SZ CAT No: | SZ-C020026 |
| CAS No | 137054-66-1 |
| Mol.F. | C24H23ClN2O6S |
| Mol.Wt. | 503.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cefdinir Impurity 4 is chemically 4-Methoxybenzyl (6R,7R)-3-(chloromethyl)-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 5-oxide. Cefdinir Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Cefdinir Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cefdinir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 137054-66-1
Purchase 137054-66-1
Order 137054-66-1
Enquire 137054-66-1
price of 137054-66-1
137054-66-1 Supplier
137054-66-1 Manufacturer
137054-66-1 Exporter
buy high quality Cefdinir Impurity 4
Purchase Cefdinir Impurity 4
Cefdinir Impurity 4 suppliers
Cefdinir Impurity 4 manufacturers
Cefdinir Impurity 4 price
Order Cefdinir Impurity 4
Enquire Cefdinir Impurity 4
Cefdinir Impurity 4 cost
Cefdinir Impurity 4 Supplier
Cefdinir Impurity 4 Distributor
Cefdinir Impurity 4 for Method Validation
Cefdinir Reference Standard
Cefdinir Impurity 4 for ANDA Filing
Cefdinir Impurity 4 for Forced Degradation Studies
Cefdinir Impurity 4 Identification Standards
Cefdinir Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


